皮質死滅 (スティーブンズ・ジョンソン症候群/毒性皮質死滅) に対する全身免疫調節療法:体系的なレビューとメタ解析
Ruben Heuer1, Maren Paulmann2, Maja Mockenhaupt2
1Division of Evidence-based Medicine (dEBM), Department of Dermatology, Venereology and Allergy, Charité - University Medicine Berlin, Corporate Member of Free University of Berlin, Humboldt University of Berlin, and Berlin Institute of Health, Berlin, Germany.
まとめ
系統免疫調節療法 (SIT) は,表皮解剖 (EN) に限られた効果を示している. エタネセプトは,サポートケアのみと比較して死亡率の改善を示した.
科学分野:
- 皮膚科
- 臨床薬理学
- 証拠 に 基づく 医学
背景:
- エピデルマ・ネクロライシス (EN) は,重症で稀な皮膚反応で,死亡率が高い.
- ENに対する全身免疫調節療法 (SIT) の有効性に関する証拠は限られている.
- 現在の治療ガイドラインは サポートケアを強調しています
研究 の 目的:
- ENに対するSITの有効性をサポートケアや他のSITと比較して体系的に検討し,比較する.
- SITが死亡率,入院,再表皮化,合併症,後遺症に及ぼす影響を評価する.
- EN管理のための証拠に基づいた勧告を提供すること.
主な方法:
- ランダム化制御試験と制御観察試験の体系的レビューとランダム効果メタ分析.
- 含有基準: EN分類 (Bastuji- Garin, 1993), ≥5人の患者/ 腕,有意な基準差はない.
- 検索したデータベース: MEDLINE,Embase,Cochrane CENTRAL (1993〜2024年) 58件の治療比較を対象とした43件の研究を分析した.
主要な成果:
- サイクロスポリンはIVIGよりも死亡率の減少に優れている (RR 0. 18).
- コルチコステロイドとIVIGは,単独のコルチコステロイドと比較して重篤な合併症 (セプシス) を減少させた (RR 0. 77).
- Etanerceptは,不正確で不明確な臨床的重要性にもかかわらず,サポートケアと比較して有意な死亡率の利益を示しました (RR 0. 32).
結論:
- エピデルマ・ネクロリシスのサポートケアよりもSITの優位性を支持する明確な証拠はありません.
- サポートケアは EN治療の基石です
- EN管理における特定のSITの役割を明確にするには,さらに質の高い研究が必要です.
関連する概念動画
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:26Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
01:24Nephrotic Syndrome III : Nursing Management
41
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
41
01:28Inflammatory Response
6.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
6.9K